These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


264 related items for PubMed ID: 15623618

  • 1. Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
    Vaughan HA, Svobodova S, Macgregor D, Sturrock S, Jungbluth AA, Browning J, Davis ID, Parente P, Chen YT, Stockert E, St Clair F, Old LJ, Cebon J.
    Clin Cancer Res; 2004 Dec 15; 10(24):8396-404. PubMed ID: 15623618
    [Abstract] [Full Text] [Related]

  • 2. Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number.
    Sato S, Noguchi Y, Wada H, Fujita S, Nakamura S, Tanaka R, Nakada T, Hasegawa K, Nakagawa K, Koizumi F, Ono T, Nouso K, Jungbluth A, Chen YT, Old LJ, Shiratori Y, Nakayama E.
    Int J Oncol; 2005 Jan 15; 26(1):57-63. PubMed ID: 15586225
    [Abstract] [Full Text] [Related]

  • 3. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
    Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J, Intengan M, Beck A, Keitz B, Santiago D, Williamson B, Scanlan MJ, Ritter G, Chen YT, Driscoll D, Sood A, Lele S, Old LJ.
    Cancer Res; 2003 Sep 15; 63(18):6076-83. PubMed ID: 14522938
    [Abstract] [Full Text] [Related]

  • 4. Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues.
    Wang XY, Chen HS, Luo S, Zhang HH, Fei R, Cai J.
    Oncol Rep; 2009 Mar 15; 21(3):713-9. PubMed ID: 19212631
    [Abstract] [Full Text] [Related]

  • 5. Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
    Sharma P, Gnjatic S, Jungbluth AA, Williamson B, Herr H, Stockert E, Dalbagni G, Donat SM, Reuter VE, Santiago D, Chen YT, Bajorin DF, Old LJ.
    Cancer Immun; 2003 Dec 18; 3():19. PubMed ID: 14680360
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
    Li M, Yuan YH, Han Y, Liu YX, Yan L, Wang Y, Gu J.
    Clin Cancer Res; 2005 Mar 01; 11(5):1809-14. PubMed ID: 15756003
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma.
    Goydos JS, Patel M, Shih W.
    J Surg Res; 2001 Jun 15; 98(2):76-80. PubMed ID: 11397121
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.
    Prasad ML, Jungbluth AA, Patel SG, Iversen K, Hoshaw-Woodard S, Busam KJ.
    Head Neck; 2004 Dec 15; 26(12):1053-7. PubMed ID: 15515159
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue.
    Hudolin T, Juretic A, Spagnoli GC, Pasini J, Bandic D, Heberer M, Kosicek M, Cacic M.
    Prostate; 2006 Jan 01; 66(1):13-8. PubMed ID: 16114059
    [Abstract] [Full Text] [Related]

  • 16. Expression of MAGE-A1, MAGE-A3/4 and NY-ESO-1 cancer-testis antigens in fetal testis.
    Hudolin T, Kastelan Z, Derezić D, Basić-Jukić N, Cesare Spagnoli G, Juretić A, Jezek D.
    Acta Dermatovenerol Croat; 2009 Jan 01; 17(2):103-7. PubMed ID: 19595265
    [Abstract] [Full Text] [Related]

  • 17. [Expression of NY-ESO-1 and LAGE-1 cancer-testis antigens in hepatocellular carcinoma].
    Zhang WM, Xiao G, Zhang M, Guo AL, Dong Y, Wen JM.
    Zhonghua Bing Li Xue Za Zhi; 2005 Apr 01; 34(4):202-5. PubMed ID: 16091172
    [Abstract] [Full Text] [Related]

  • 18. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA, Franklin WA.
    Cancer Res; 2002 Jul 15; 62(14):3971-9. PubMed ID: 12124329
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
    Ries J, Mollaoglu N, Vairaktaris E, Neukam FW, Nkenke E.
    Anticancer Res; 2009 Dec 15; 29(12):5125-30. PubMed ID: 20044626
    [Abstract] [Full Text] [Related]

  • 20. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.
    Lu Y, Wu LQ, Lü ZH, Wang XJ, Yang JY.
    Chin Med J (Engl); 2007 Jun 20; 120(12):1042-6. PubMed ID: 17637219
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.